contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


swedish-based-analyst-group-releases-first-commissioned-equity-research-of-brain-as-and-base-case-values-the-company-at-dkk-41-per-share

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Brain+ are a pharmaceutical company. The company specializes in research and development for the treatment of dementia and Alzheimer's. The product portfolio includes, for example, cognitive stimulation therapy. In addition to the main business, service and associated ancillary services are also offered. The business is run with the largest presence in Europe. Brain+ is headquartered in Copenhagen.

Brain+

SummaryAnalyst Group's base case values Brain+ at a EUR 8.5m Enterprise Value in 2024 - a ~142% premium to the current value.Analyst Group's equity research paper presents three (3) per share...

Summary<ul><li>Analyst Group's base case values Brain+ at a EUR 8.5m Enterprise Value in 2024 - a ~142% premium to the current value.</li><li>Analyst Group's equity research paper presents three (3) per share valuation cases for Brain+ BRAINP shares. The base case is DKK 4.1 per share, the Bull case is DKK 6.4, and the Bear case is DKK 1.7.</li><li>The valuation is based exclusively on Analyst Group's forecasts for the Brain+ CST product suite in Denmark and Germany, and excludes additional potential from launch in additional geographic markets (Brain+ plans to enter 1-2 new markets every year from 2023), from other Brain+ products and technologies in the pipeline (Computerized Cognitive Training for Mild Cognitive Impairment, and the Starry Night Memory test), and deals with prospective pharmaceutical partners (Analyst Group identifies an estimated EUR 24m potential deal value derived from these by 2027).</li></ul>See the report here: Analyst-Group-Brain.pdf (analystgroup.se)&nbsp;(<a href="https://analystgroup.se/wp-content/uploads/2022/10/Analyst-Group-Brain.pdf">https://analystgroup.se/wp-content/uploads/2022/10/Analyst-Group-Brain.pdf</a>)About Analyst Group researchAnalyst Group was founded in 2014, a time when information available on small and medium-sized companies was considered deficient. Therefore, Analyst Group's founders chose to start up an equity research firm with the vision to illuminate and disseminate correct information to provide better support in investment decisions.Contact InformationCEO, Kim Baden-Kristensen + 45 31393317, E-mail: kim@brain-plus.com,Brain+ A/S, Købmagergade 53, 3.Disclaimer: Brain+ has an agreement with Analyst Group to undertake commissioned research. Any opinions, estimates or forecasts regarding Brain+`s performance are made by Analyst Group, and solely reflect the analyst's opinion and does not represent the opinions, forecasts or predictions of Brain+ or its management. Reference to the content above, does not imply Brain+`s endorsement of such information, conclusions or recommendations.

Swedish-based Analyst Group releases first commissioned equity research of Brain+ A/S and base case values the company at DKK 4.1 per share